| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36f12690a646f4748ac2bdf53149359a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bfb57f2d9d8c6a78e97a49cff650b8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4443aa53062c1e88eeb7a32b8874b3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ccabf42596331de22428609835e3b745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a52e064071ce391c93bcc97464eb7850 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-343 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1135 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate |
2014-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b872e4568b463e1a684977f5fb60d021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88871bdb6eb97c34f3e7974e618808eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed92f33596bf65c74521bf44862eff7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43d718a8ffb46cdbb6d67454e6db66bd |
| publicationDate |
2014-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014140922-A1 |
| titleOfInvention |
Methods for treating chronic kidney disease |
| abstract |
The present invention relates to methods for treating chronic kidney disease (CKD) including methods for preventing or delaying onset of CKD and methods for preventing exacerbation and progression of CKD. In particular embodiments, the invention provides methods for treating a subject at risk of developing CKD comprising administering to the subject a composition comprising a) a therapeutically effective amount of at least one oligonucleotide compound which inhibits the expression of a human target gene associated with the kidney disease; and b) a pharmaceutically acceptable excipient or carrier, or mixtures thereof, thereby reducing the risk of CKD in the subject. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018027149-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4035659-A1 |
| priorityDate |
2009-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |